Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kesara Na-Bangchang. (2009) Pharmacodynamics of antimalarial chemotherapy. Expert Review of Clinical Pharmacology 2:5, pages 491-515.
Read now
Read now
Articles from other publishers (30)
V. N. Perfilova. (2023) Opportunities and Prospects for Preclinical Drug Safety Assessment Using Alternative Methods: Experience from the Toxicology in the 21st Century (Tox21) Programme in the USA. Safety and Risk of Pharmacotherapy.
Crossref
Crossref
Alessandra Teixeira Vidal-Diniz, Homero Nogueira Guimarães, Giani Martins Garcia, Érika Martins Braga, Sylvain Richard, Andrea Grabe-Guimarães & Vanessa Carla Furtado Mosqueira. (2022) Polyester Nanocapsules for Intravenous Delivery of Artemether: Formulation Development, Antimalarial Efficacy, and Cardioprotective Effects In Vivo. Polymers 14:24, pages 5503.
Crossref
Crossref
Khalil Saadeh, Nakulan Nantha Kumar, Ibrahim Talal Fazmin, Charlotte E. Edling & Kamalan Jeevaratnam. (2022) Anti‐malarial drugs: Mechanisms underlying their proarrhythmic effects. British Journal of Pharmacology 179:24, pages 5237-5258.
Crossref
Crossref
Elvira D’Andrea, Rishi J. Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt & Seoyoung C. Kim. (2022) Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. Journal of the American College of Cardiology 80:1, pages 36-46.
Crossref
Crossref
Teresa Maria Creanza, Pietro Delre, Nicola Ancona, Giovanni Lentini, Michele Saviano & Giuseppe Felice Mangiatordi. (2021) Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study. Journal of Chemical Information and Modeling 61:9, pages 4758-4770.
Crossref
Crossref
Romain Muller. (2021) Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatology International 41:7, pages 1189-1202.
Crossref
Crossref
Ashok Kumar, Rita Singh, Jaskaran Kaur, Sweta Pandey, Vinita Sharma, Lovnish Thakur, Sangeeta Sati, Shailendra Mani, Shailendra Asthana, Tarun Kumar Sharma, Susmita Chaudhuri, Sankar Bhattacharyya & Niraj Kumar. (2021) Wuhan to World: The COVID-19 Pandemic. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku‐Betts, Ana Alfirevic, David Back, Saye H. Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park, Xiaoli Meng, Christopher E. Goldring & Amy E. Chadwick. (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology 177:19, pages 4353-4374.
Crossref
Crossref
Ulf Norinder, Astrud Tuck, Kalle Norgren & Vesna Munic Kos. (2020) Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19. Biomedicine & Pharmacotherapy 130, pages 110582.
Crossref
Crossref
Kanigula Mubagwa. (2020) Cardiac effects and toxicity of chloroquine: a short update. International Journal of Antimicrobial Agents 56:2, pages 106057.
Crossref
Crossref
L. Epelboin, C. Rapp, J.F. Faucher, F. Méchaï, E. Bottieau, S. Matheron, D. Malvy & E. Caumes. (2020) Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines. Médecine et Maladies Infectieuses 50:2, pages 194-212.
Crossref
Crossref
Julie Gutman, Stephanie Kovacs, Grant Dorsey, Andy Stergachis & Feiko O ter Kuile. (2017) Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis. The Lancet Infectious Diseases 17:2, pages 184-193.
Crossref
Crossref
Shufeng Zhou. 2016. Cytochrome P450 2D6. Cytochrome P450 2D6
139
288
.
Thierry T. Diagana. (2015) Supporting malaria elimination with 21st century antimalarial agent drug discovery. Drug Discovery Today 20:10, pages 1265-1270.
Crossref
Crossref
Vasiliy Korotchenko, Ramadas Sathunuru, Lucia Gerena, Diana Caridha, Qigui Li, Mara Kreishman-Deitrick, Philip L. Smith & Ai J. Lin. (2015) Antimalarial Activity of 4-Amidinoquinoline and 10-Amidinobenzonaphthyridine Derivatives. Journal of Medicinal Chemistry 58:8, pages 3411-3431.
Crossref
Crossref
Amos O. Abolaji, Fenose Osedeme & Oluwatosin Olusemire. (2014) Artesunate-amodiaquine combination therapy in the absence of malarial parasite infection induces oxidative damage in female rats. Cell Biochemistry and Function 32:3, pages 303-308.
Crossref
Crossref
Gül Erdemli & Ruth L. Martin. 2014. Predictive ADMET. Predictive ADMET
407
431
.
Chiagoziem A. Otuechere, Gloria Edewor, Oluwafemi Ezekiel Kale & Martins Ekor. (2012) Subacute Therapeutic Dosing of Artemether-Lumefantrine and Artesunate-Amodiaquine Combination Preserves Plasma Cholesterol, Renal Antioxidant Status, and Organ Weights in Rats. Malaria Research and Treatment 2012, pages 1-5.
Crossref
Crossref
Laszlo Urban, Steven Whitebread, Jacques Hamon, Dmitri Mikhailov & Kamal Azzaoui. 2012. Polypharmacology in Drug Discovery. Polypharmacology in Drug Discovery
15
46
.
Rina P. M. Wong, Sam Salman, Kenneth F. Ilett, Peter M. Siba, Ivo Mueller & Timothy M. E. Davis. (2011)
Desbutyl-Lumefantrine Is a Metabolite of Lumefantrine with Potent
In Vitro
Antimalarial Activity That May Influence Artemether-Lumefantrine Treatment Outcome
. Antimicrobial Agents and Chemotherapy 55:3, pages 1194-1198.
Crossref
Crossref
J.O. Adebayo, A. Igunnu, R.O. Arise & S.O. Malomo. (2011) Effects of co-administration of artesunate and amodiaquine on some cardiovascular disease indices in rats. Food and Chemical Toxicology 49:1, pages 45-48.
Crossref
Crossref
Michael PfallerNatasha Holmes & M Grayson. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition
1037
1075
.
Matthias RottmannCase McNamaraBryan K. S. YeungMarcus C. S. LeeBin ZouBruce RussellPatrick SeitzDavid M. PlouffeNeekesh V. DhariaJocelyn TanSteven B. CohenKathryn R. SpencerGonzalo E. González-PáezSuresh B. LakshminarayanaAnne GohRossarin SuwanaruskTimothy JeglaEsther K. SchmittHans-Peter BeckReto BrunFrancois NostenLaurent ReniaVeronique DartoisThomas H. KellerDavid A. FidockElizabeth A. WinzelerThierry T. Diagana. (2010) Spiroindolones, a Potent Compound Class for the Treatment of Malaria. Science 329:5996, pages 1175-1180.
Crossref
Crossref
John A. Camm, Amin Al‐Ahmad, David S. Cannom, Jeronimo Farré, Mark E. Josephson & Hein J. J. Wellens. 2009. Ventricular Tachycardia/Fibrillation Ablation. Ventricular Tachycardia/Fibrillation Ablation
1
45
.
Salim Abdulla, Issaka Sagara, Steffen Borrmann, Umberto D'Alessandro, Raquel González, Mary Hamel, Bernhards Ogutu, Andreas Mårtensson, John Lyimo, Hamma Maiga, Philip Sasi, Alain Nahum, Quique Bassat, Elizabeth Juma, Lucas Otieno, Anders Björkman, Hans Peter Beck, Kim Andriano, Marc Cousin, Gilbert Lefèvre, David Ubben & Zulfikarali Premji. (2008) Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. The Lancet 372:9652, pages 1819-1827.
Crossref
Crossref
Nicholas J White. (2007) Cardiotoxicity of antimalarial drugs. The Lancet Infectious Diseases 7:8, pages 549-558.
Crossref
Crossref
Sharon I Omoruyi, Cyprian O Onyeji & Michael O Daniyan. (2007) Effects of Prior Administration of Amodiaquine on the Disposition of Halofantrine in Healthy Volunteers. Therapeutic Drug Monitoring 29:2, pages 203-206.
Crossref
Crossref
Effrossyni Gkrania-Klotsas & Andrew M.L. Lever. (2007) An update on malaria prevention, diagnosis and treatment for the returning traveller. Blood Reviews 21:2, pages 73-87.
Crossref
Crossref
Michael M. Gepp & Michael C. Hutter. (2006) Determination of hERG channel blockers using a decision tree. Bioorganic & Medicinal Chemistry 14:15, pages 5325-5332.
Crossref
Crossref
Yetunde T. Kolade, Chinedum P. Babalola & Gerhard K.E. Scriba. (2006) Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 41:1, pages 315-319.
Crossref
Crossref